These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16202333)

  • 1. [Human Immunodeficiency Virus type 1 seroincidence estimate among a group of drug users: a new approach].
    Fernandes SB; Martins HC; Trigo H; Leitão E; Coutinho R; Paixão MT
    Acta Med Port; 2005; 18(1):37-44. PubMed ID: 16202333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.
    Hartel DM; Schoenbaum EE
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):107-15. PubMed ID: 9722816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
    Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
    Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.
    Chawla A; Murphy G; Donnelly C; Booth CL; Johnson M; Parry JV; Phillips A; Geretti AM
    J Clin Microbiol; 2007 Feb; 45(2):415-20. PubMed ID: 17151211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
    Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons.
    Ramaswamy M; Sabin C; McDonald C; Smith M; Taylor C; Geretti AM
    Sex Transm Dis; 2006 Feb; 33(2):96-101. PubMed ID: 16432480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
    Lucas GM; Griswold M; Gebo KA; Keruly J; Chaisson RE; Moore RD
    Am J Epidemiol; 2006 Mar; 163(5):412-20. PubMed ID: 16394200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
    Clifford GM; Rickenbach M; Polesel J; Dal Maso L; Steffen I; Ledergerber B; Rauch A; Probst-Hensch NM; Bouchardy C; Levi F; Franceschi S;
    AIDS; 2008 Oct; 22(16):2135-41. PubMed ID: 18832877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of skin disorders in human immunodeficiency virus-infected patients in Singapore and the relationship to CD4 lymphocyte counts.
    Goh BK; Chan RK; Sen P; Theng CT; Tan HH; Wu YJ; Paton NI
    Int J Dermatol; 2007 Jul; 46(7):695-9. PubMed ID: 17614796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
    Shores NJ; Maida I; Soriano V; Núnez M
    J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term, medically supervised, drug-free treatment and methadone maintenance treatment on drug users' emergency department use and hospitalization.
    Turner BJ; Laine C; Yang CP; Hauck WW
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S457-63. PubMed ID: 14648464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches.
    Bernstein KT; Liu KL; Begier EM; Koblin B; Karpati A; Murrill C
    Arch Intern Med; 2008 Jul; 168(13):1458-64. PubMed ID: 18625927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
    Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
    J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B; Narayanan S; Navaratnam V
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Settings for identifying recent HIV infections: the Portuguese experience.
    Cortes Martins H; Paixao M
    Euro Surveill; 2008 Sep; 13(36):. PubMed ID: 18775290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.